Keyphrases
Temozolomide
100%
Evade
100%
Cell Culture
100%
Blood-brain Barrier
63%
Canine
62%
Cancer Patients
62%
Brain Cancer
56%
Invasive Urothelial Carcinoma
50%
Primary Bone Tumor
50%
Resistance Mechanisms
50%
Runt-related Transcription Factor 2 (Runx2)
50%
Disease-based
50%
Differential Expression
50%
Imidazotetrazines
50%
Alkaline Phosphatase
50%
Efflux
50%
High-grade Meningioma
50%
PAC1
50%
Radiosensitization
50%
Carcinoma
50%
Procaspase-3 Activator
50%
Osteosarcoma
50%
Prostate-specific Antigen
50%
Agnostic
50%
Hydroxyurea
50%
Strategy Concept
50%
Canine Cancer
50%
P-glycoprotein (P-gp)
50%
BRAF Inhibitor (BRAFi)
50%
Yield Optimization
50%
Companion Animals
50%
Prostate Carcinoma
38%
Meningioma
31%
Radiotherapy
31%
P-glycoprotein Efflux
30%
Tumor
28%
Penetrance
27%
Penetrant
26%
Ionizing Radiation
25%
Human Cancer
25%
Glioblastoma
21%
Dabrafenib
20%
Central Nervous System
20%
Overexpression
17%
Prostate Carcinoma Cell Lines
16%
Patient Samples
16%
Anticancer Activity
15%
Methylguanine Methyltransferase
14%
Mismatch Repair
14%
Locoregional
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cell Culture
100%
Temozolomide
100%
Malignant Neoplasm
84%
Neoplasm
60%
Brain Cancer
55%
Procaspase 3
50%
Hydroxycarbamide
50%
Meningioma
50%
Effusion
50%
P-Glycoprotein
50%
Blood-Brain Barrier
47%
Glioblastoma
35%
Ionizing Radiation
20%
DNA Methyltransferase
14%
Dabrafenib
14%
Metastatic Melanoma
14%
Intracranial Tumor
12%
Biodistribution
7%
Prodrug
7%
Maximum Tolerated Dose
7%
Methylated DNA Protein Cysteine Methyltransferase
7%
Carboxylate
7%
Mouse Model
7%
Tracer
5%
Pet Animal
5%
Overall Survival
5%
Fluorine 18
5%
Diseases
5%
Medicine and Dentistry
Prostate Specific Membrane Antigen
50%
Radiosensitization
50%
Transitional Cell Carcinoma
50%
Carcinoma
50%
Effusion
50%
ABC Transporter Subfamily B
50%
Radiation Therapy
50%
Diseases
50%
Prostate Carcinoma
38%
Neoplasm
37%
Blood Brain Barrier
35%
Malignant Neoplasm
25%
Ionizing Radiation
25%
Cancer
23%
Prostate Carcinoma Cell Line
16%
Dabrafenib
14%
Central Nervous System
14%
Penetrance
14%
Metastatic Melanoma
14%
Antineoplastic Activity
12%
Drug Dose Intensification
12%
Tumor Cell
12%
Tumor Histology
12%
External Beam Radiotherapy
12%
Conformal Radiotherapy
12%
Protein Expression
11%
Vinblastine
11%
Cell Line
11%
In Vitro
11%
Carboxylic Acid
7%
Ganglioglioma
7%
Solid Malignant Neoplasm
5%
Gene Expression
5%
Membrane Protein
5%
Clinical Management
5%
Tumor Progression
5%
Antigen Expression
5%
Cytotoxicity
5%
First-Line Chemotherapy
5%
Cisplatin
5%
Docetaxel
5%
